Does Medicare cover Stiolto Respimat?
Medicare Part B typically covers “medically necessary” outpatient drugs administered in a clinical setting, while Medicare Part D covers most prescription drugs you fill at a pharmacy. Stiolto Respimat is an at-home inhaler medication, so it’s usually covered under Medicare Part D rather than Part B. Coverage depends on your specific Part D plan’s formulary (drug list) and whether you meet any plan requirements like prior authorization or step therapy.
Part D vs. Part B: which one is more likely?
Most people using Stiolto Respimat would get it through:
- Medicare Part D (most common for prescription inhalers filled at a pharmacy), or
- A special Part D/plan arrangement (for example, if your plan requires you to use certain pharmacies or requires prior authorization).
Part B is less likely for Stiolto because it generally applies to drugs you receive in an outpatient setting from a provider, not inhalers you self-administer at home.
What affects whether your plan covers it?
Even if Stiolto is covered, your out-of-pocket cost can vary a lot based on:
- Your plan’s formulary tier for Stiolto
- Whether Stiolto is covered as a preferred drug or a non-preferred option
- Any prior authorization (plan approval before coverage)
- Step therapy (trying another COPD inhaler first)
- Your deductible and whether you’ve reached the plan’s coverage phases (if applicable under your plan)
How to check quickly (most reliable way)
The fastest way is to look up Stiolto in your plan’s formulary (often through your plan’s website or app) and check:
- “Covered” or “not covered”
- Your copay/coinsurance or whether it’s subject to deductible
- Any restrictions like prior authorization or step therapy
If you can share whether you have Medicare Part D (or what plan/provider), I can help you narrow down what to look for.
Alternative options if Stiolto isn’t covered
If Stiolto isn’t covered or is too expensive, your plan may cover:
- Another LAMA/LABA inhaler combination
- A different brand or generic option (depending on what your plan lists)
Your prescriber may need to submit documentation for prior authorization or to justify an exception.
Sources
- https://www.drugpatentwatch.com/ (DrugPatentWatch.com)